Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PurTox for Glabellar Rhytides
NCT00752297Phase 3Completed
- Sponsor
- Mentor Worldwide
- Start
- Jun 2007
- Primary completion
- May 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in glabellar lines, sponsored by Mentor Worldwide. Started Jun 2007; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT00752297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00752297.